Key Takeaways
- • Prosper AI raised $30 million in Series A funding led by Andreessen Horowitz, with participation from Base10, Emergence Capital, Y Combinator, and Company Ventures, nine months after its seed round announcement.
- • The company's AI platform automates the entire patient journey end-to-end, including scheduling, insurance verification, patient billing, and prior authorization workflows, helping providers reduce administrative costs by over 40%.
- • Prosper AI's voice AI agents currently manage workflows across more than 150,000 patient interactions, positioning the startup as a broad healthcare operations automation platform rather than a point-solution provider.
- • The funding will be deployed to expand engineering and customer-facing teams while deepening integrations with major EHR platforms, signaling a strategy to embed the platform across hospital and provider systems.
- • Co-founder and co-CEO Xavier de Gracia articulated a three-to-five-year vision where larger patient groups and health systems will deploy a hybrid AI-human workforce across multiple coordination channels—voice, APIs, fax, and browser-based interfaces—integrated with electronic health records.
Summary
Prosper AI, a healthcare artificial intelligence startup focused on automating administrative workflows, secured $30 million in Series A funding led by prominent venture capital firm Andreessen Horowitz. The round represents a significant institutional validation of the company's agentic AI approach to healthcare operations, coming nine months after the company closed its seed funding round.
The platform addresses a critical operational challenge in healthcare: administrative burden on clinical staff and patient-facing functions. Prosper AI's software uses voice AI agents to handle multiple tasks across the patient journey, including inbound call answering and appointment scheduling directly into electronic health record systems, insurance benefit verification, patient billing automation, and outbound calls to insurers for prior authorization and information requests. According to available disclosures, the platform currently manages workflows across more than 150,000 patient interactions, demonstrating meaningful adoption among provider organizations.
A key differentiator in Prosper AI's positioning is its end-to-end approach to patient journey automation. While many healthcare AI vendors focus on discrete tasks—scheduling alone or billing alone—Prosper AI was architected to coordinate across the full patient lifecycle, from pre-visit through post-visit administration. The company reports that providers using its platform have achieved administrative cost reductions exceeding 40%, a metric likely to resonate with health system CFOs facing ongoing margin pressure.
Xavier de Gracia, co-founder and co-CEO, outlined an ambitious medium-term vision in which larger patient groups and health systems will develop a hybrid workforce comprising both human and AI agents over the next three to five years. Beyond voice channels, de Gracia indicated the company is building capabilities across APIs, fax, browser-based interfaces for insurance portal interaction, and deeper EHR integration—creating what he described as a comprehensive "agentic" workforce layer on top of existing clinical technology stacks.
The Series A syndicate reflects strong institutional conviction: Andreessen Horowitz led the round, with participation from Base10 Partners, Emergence Capital, Y Combinator, and Company Ventures. Prosper AI intends to deploy capital toward engineering team expansion, customer-facing headcount growth, and deeper platform integrations with the largest EHR vendors—a roadmap consistent with scaling adoption across enterprise health systems.
The platform addresses a critical operational challenge in healthcare: administrative burden on clinical staff and patient-facing functions. Prosper AI's software uses voice AI agents to handle multiple tasks across the patient journey, including inbound call answering and appointment scheduling directly into electronic health record systems, insurance benefit verification, patient billing automation, and outbound calls to insurers for prior authorization and information requests. According to available disclosures, the platform currently manages workflows across more than 150,000 patient interactions, demonstrating meaningful adoption among provider organizations.
A key differentiator in Prosper AI's positioning is its end-to-end approach to patient journey automation. While many healthcare AI vendors focus on discrete tasks—scheduling alone or billing alone—Prosper AI was architected to coordinate across the full patient lifecycle, from pre-visit through post-visit administration. The company reports that providers using its platform have achieved administrative cost reductions exceeding 40%, a metric likely to resonate with health system CFOs facing ongoing margin pressure.
Xavier de Gracia, co-founder and co-CEO, outlined an ambitious medium-term vision in which larger patient groups and health systems will develop a hybrid workforce comprising both human and AI agents over the next three to five years. Beyond voice channels, de Gracia indicated the company is building capabilities across APIs, fax, browser-based interfaces for insurance portal interaction, and deeper EHR integration—creating what he described as a comprehensive "agentic" workforce layer on top of existing clinical technology stacks.
The Series A syndicate reflects strong institutional conviction: Andreessen Horowitz led the round, with participation from Base10 Partners, Emergence Capital, Y Combinator, and Company Ventures. Prosper AI intends to deploy capital toward engineering team expansion, customer-facing headcount growth, and deeper platform integrations with the largest EHR vendors—a roadmap consistent with scaling adoption across enterprise health systems.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.